CA Stock MarketDetailed Quotes
AQS Aequus Pharmaceuticals Inc
- 0.005
- 0.0000.00%
15min DelayTrading Nov 21 16:00 ET
663.17KMarket Cap-500P/E (TTM)
0.000High0.000Low100Volume0.010Open0.005Pre Close1.00Turnover0.04052wk High0.00%Turnover Ratio132.63MShares0.00552wk Low-0.01EPS TTM563.98KFloat Cap0.800Historical HighLossP/E (Static)112.80MShs Float0.005Historical Low-0.02EPS LYR0.00%Amplitude--Dividend TTM-0.11P/B1Lot Size--Div YieldTTM
About Aequus Pharmaceuticals Inc Company
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Company Profile
SymbolAQS
Company NameAequus Pharmaceuticals Inc
Founded2013
MarketTSX
Employees15
Fiscal Year Ends12-31
Address200 Granville Street Suite 2820
CityVancouver
CountryCAN
Zip CodeV6C 1S4
Phone+1 604 336-7906
Websitehttps://www.aequuspharma.ca
Company Executives
- Name
- Position
- Salary
- Douglas Glen Janzen
- Chairman of the Board, President and Chief Executive Officer
- --
- Ann Fehr
- Chief Financial Officer and Corporate Secretary
- --
- Grant Larsen
- Chief Commercial Officer
- --
- Christopher Clark
- Director
- --
- Anne Michelle Stevens
- Independent Director
- --
- Marc Lustig
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data